Menu
Close
Through our group companies – SIA "Silvanols", SIA "JONNEX-FARMA" and AS "RĪGAS FARMACEITISKĀ FABRIKA" – Olpha offers reliable and experienced partners for supplement manufacturing.
Contact usFrom capsules to sprays and gels, we manufacture supplements in various different forms.
Bottles (syrups) glass/PET 50 – 500 ml
Bottles (drops) glass/PET 10 – 100 ml
Shots PET 10, 25, 60 ml
Jars glass/PET 20 – 500 ml
Sprays glass/PET 10 – 50 ml
Blisters capsules, tablets
Airless dispensers PET 15 – 150 ml
Tubes aluminum 10 – 100 g
We are mindful about the needs of our customers,
therefore we offer the minimum possible quantity for
the respective orders our clients place. The volume
will still depend on product type or service, but we
do our best to ensure that they are manageable.
Shots 10 500 pcs
Syrups 2 500 pcs
Sprays 5 000 pcs
Drops 2 500 pcs
Capsules 60 000 pcs
Gels/Creams (airless) 2 000 pcs
Ointments/Creams (aluminum tubes) 4 300 pcs
Powders (jars/pouches) 1 000 pcs
Shots 5 000 000 pcs
Syrups 3 500 000 pcs
Sprays 7 500 000 pcs
Drops 8 000 000 pcs
Capsules 70 000 000 pcs
Gels/Creams (airless) 250 000 pcs
Ointments/Creams (aluminum tubes) 2 700 000 pcs
Powders (jars/pouches) 1 500 000 pcs
There’s a separate R&D department for supplement manufacturing, thus we have the capabilities to not only offer our standard formulations, but also develop new formulas based on your needs and specifications.
As a contract manufacturer, we can also advise you on the various packaging options for different applications and target groups. We can also refer you to our trusted design and packaging partner if needed, and we can offer tips on the technical requirements for label printing.
production
production capacity for tablets and capsules per year
investment in R&D in 2022
investment in new generic medicine portfolio in 2024
With a team of 800+ professional employees and 50+ years of experience, Olpha is an expert in the development and production of finished dosage forms and active pharmaceutical ingredients and intermediates in a vast range of therapeutic areas.
Our production plant is located in the European Union, in Latvia, and has a 480,000 square meter area with easy access to the highway and airport. Our laboratories are equipped with modern, industry standard instruments.
We approach each client’s needs and evaluate each cooperation on an individual level. We believe the best way of collaborating is finding the most suitable solution for any need together.
Olpha is develops generics as well as APIs and stands out with the full-cycle production offering.
Olpha ensures consistent product availability to meet the market demand.
Efficient production processes, lower labour costs and regionally developed logistics result in greater cost efficiency.
Olpha holds its production to the highest industry quality standards. See more information on quality control and assurance on our Product governance page.
Our processes include effective sustainability measures, ensuring that our business processes are good for people and the planet. See more information on our Sustainability section.
